Ronsin C, Chung-Scott V, Poullion I, Aknouche N, Gaudin C, Triebel F
Laboratoire d'Immunologie Cellulaire, Institut Gustave-Roussy, Villejuif, France.
J Immunol. 1999 Jul 1;163(1):483-90.
A number of Ags recognized by tumor-reactive T cells have been characterized, including nonmutated gene products and a variety of epitopes shown to arise from either mutated or alternatively processed transcripts. Here, we report that the screening of a cDNA library with an HLA-B7-restricted renal cell carcinoma-reactive T cell clone derived from tumor-infiltrating lymphocytes (TILs) that were clonally amplified in vivo (as assessed by TCRBV complementarity determining region-3 length distribution analysis) resulted in the isolation of a nonamer encoded by an alternative open reading frame (ORF) (a +1 frameshift) of the intestinal carboxyl esterase gene. This peptide binds HLA-B*0702-presenting molecules as assessed in an immunofluorescence-based peptide binding assay using transfected T2 cells. Constitutive expression of this alternative ORF protein was observed in all transformed HLA-B7+ renal cell lines that were recognized in cytotoxicity assays by the TILs. The intestinal carboxyl esterase gene is transcribed in renal cell carcinoma tumors as well as in normal liver, intestinal, or renal tissues. Mutation of the natural ATG translation initiation site did not alter recognition, indicating that frameshifting (i.e., slippage of the ribosome forward) and recoding are not involved. In addition, a point mutation of the three AUG codons that may be used as alternative translation initiation sites in the +1 ORF did not abolish recognition, whereas mutation of an upstream ACG codon did, indicating that the latter codon initiates the translation of the alternative ORF. These results further extend the types of Ags that can be recognized by tumor-reactive TILs in situ (i.e., leading to clonal T cell expansion).
多种可被肿瘤反应性T细胞识别的抗原已得到鉴定,包括未突变的基因产物以及多种由突变或可变剪接转录本产生的表位。在此,我们报告,用一个HLA - B7限制性肾细胞癌反应性T细胞克隆筛选cDNA文库,该克隆源自肿瘤浸润淋巴细胞(TILs),这些TILs在体内进行了克隆扩增(通过TCRBV互补决定区 - 3长度分布分析评估),结果分离出一种由肠羧基酯酶基因的可变开放阅读框(ORF)(+1移码)编码的九肽。在使用转染的T2细胞进行的基于免疫荧光的肽结合试验中评估发现,该肽与呈递HLA - B*0702的分子结合。在细胞毒性试验中被TILs识别的所有转化的HLA - B7 +肾细胞系中均观察到这种可变ORF蛋白的组成性表达。肠羧基酯酶基因在肾细胞癌肿瘤以及正常肝、肠或肾组织中均有转录。天然ATG翻译起始位点的突变并未改变识别,这表明移码(即核糖体向前滑动)和重新编码并不涉及。此外,在 +1 ORF中可能用作替代翻译起始位点的三个AUG密码子的点突变并未消除识别,而上游ACG密码子的突变则消除了识别,这表明后者密码子启动了可变ORF的翻译。这些结果进一步扩展了原位肿瘤反应性TILs(即导致克隆性T细胞扩增)可识别的抗原类型。